1. 75,600 People Diagnosed with COPD, COPD Hospitalizations Increase by 9% in 2025 (PHE).

In the context of respiratory health becoming a major concern in the US, recent statistics from reputable sources like the CDC and American Lung Association paint an alarming picture of chronic obstructive pulmonary disease (COPD). According to forecasts from Renub Research, the COPD market in the US is projected to reach a value of 4.92 billion USD by 2033, up from 3.97 billion USD in 2024, reflecting a significant increase in case numbers and related healthcare costs. Specifically, over 16 million adults in the US are living with COPD, and this number is expected to continue rising due to environmental and lifestyle factors. Furthermore, the rate of hospitalizations due to COPD has increased by about 9% compared to the previous year, based on data from CDC reports in 2025, with over 75,600 new diagnoses recorded just this year. These figures not only highlight the economic burden but also point to the urgent need for specialized consultation solutions, especially through online meetings, allowing patients to access global pulmonology experts without being limited by geographic distance. This opens up a second chance for millions, where connection technology can effectively improve quality of life.

To illustrate more clearly, consider the real-life story of Mr. Johnathan Miller, a 58-year-old construction engineer living in Chicago, Illinois. Mr. Johnathan had smoked cigarettes for over 30 years due to work pressure, and in early 2025, he began experiencing severe shortness of breath, accompanied by persistent coughing and constant fatigue. Initially, he thought it was just a sign of aging, but after a severe episode of shortness of breath while working on a construction site, he had to be rushed to the hospital. Doctors diagnosed him with moderate-stage COPD, with a high hospitalization rate due to urban air pollution. This situation not only affected his health but also caused emotional stress: he felt anxious about his job future, fearing loss of work capacity and financial burden on his family, including his wife and two sons. The initial resolution direction was to use bronchodilators and monitoring at a local hospital, but due to a packed schedule, he often missed appointments. The specific resolution process began when he joined an online consultation program through the StrongBody AI platform, where he connected with a pulmonology expert from Canada. Through weekly online meetings, the expert analyzed his medical history, measured respiratory metrics via a mobile app, and adjusted the treatment plan including deep breathing exercises, introducing nutritional guidance, and recommending reduced exposure to construction dust. Results achieved after 6 months: he reduced the frequency of shortness of breath by 40%, decreased hospitalizations from 3 times/year to 1 time, improved sleep quality, and increased work productivity by 25%. From an economic perspective, he saved about 2,500 USD in travel and medical visit costs, while feeling more confident in daily life, helping his family reduce worry.

2. What is Chronic Respiratory Disease? Including COPD, Asthma.

Chronic respiratory disease refers to long-term pathological conditions affecting the respiratory system, causing a decline in lung and airway function over time. According to definitions from Mayo Clinic and CDC, they include major diseases such as COPD (chronic obstructive pulmonary disease), asthma, and other forms like emphysema or chronic bronchitis. COPD is characterized by irreversible airflow obstruction, while asthma involves reversible airway inflammation, leading to sudden spasms. In the US, over 28 million people are living with asthma, according to AAFA reports in 2025, while COPD affects about 11.1 million adults, with higher rates in those over 65. These diseases not only limit physical symptoms but also impact overall health, requiring long-term management from pulmonology experts.

In a real-life context, let’s talk about Mrs. Emily Rodriguez, a 45-year-old high school teacher in Los Angeles, California, who has faced chronic asthma since her teenage years. Mrs. Emily lives in an urban area with high pollution levels from traffic, and in the summer of 2025, she experienced more frequent asthma attacks, accompanied by chest tightness and nighttime coughing, causing her to take multiple days off from teaching. This issue not only stopped at health but also affected emotions: she felt helpless when unable to participate in extracurricular activities with students, leading to mild depression and family stress with her husband and daughter. The resolution direction started from seeking online consultation, where through StrongBody AI, she connected with a pulmonology expert from Brazil. The detailed resolution process included an initial evaluation via video call to determine the type of asthma (allergic to dust and pollen), followed by a plan with daily controller inhalers, daily monitoring of peak flow metrics via an app, and nutritional advice to boost the immune system. Results after 4 months: she reduced asthma attacks from 5 times/week to 1 time, improved sleep by 60%, increased teaching capacity without fatigue, and from a social perspective, she rejoined school events, bringing joy to her family and students.

3. Causes: Air Pollution, Smoking, Genetics.

The main causes of chronic respiratory diseases in the US include air pollution, smoking, and genetic factors, according to studies from the American Lung Association and WHO. Air pollution from car emissions and industry accounts for a large proportion, with over 40% of the US population living in areas with poor air quality, leading to chronic lung inflammation. Smoking is the leading factor, causing 85-90% of COPD cases, while genetics like alpha-1 antitrypsin deficiency affect about 1-2% of cases. Data from CDC in 2025 shows that disease rates increase by 15% in urban areas due to pollution, emphasizing the need for in-depth consultation to mitigate risks.

The real-life story here is about Mr. Marcus Thompson, a 52-year-old truck driver in Houston, Texas, who has a history of smoking since age 20 and working in dusty environments. In March 2025, he began experiencing shortness of breath during long-haul drives, accompanied by coughing with phlegm, and tests showed COPD due to a combination of smoking and exposure to diesel fumes. This situation had a major impact: he worried about losing his job, felt guilty towards his wife and three children because of the financial burden from medical costs of about 1,200 USD/month. The resolution direction was smoking cessation combined with online pulmonology consultation through StrongBody AI, where he connected with an expert from India. The process included genetic evaluation via online testing, a smoking cessation plan with nicotine replacement, daily exercise, and weekly monitoring to adjust. Results: he quit smoking completely after 3 months, reduced symptoms by 50%, maintained work with higher productivity, saved 800 USD/month in medication costs, and improved family relationships thanks to better health.

4. Mechanism: Chronic Lung Inflammation Leading to Shortness of Breath, Serious Complications.

The biological mechanism of chronic respiratory diseases involves chronic inflammation in the lungs, according to StatPearls and Mayo Clinic. In COPD, smoke or pollution damages alveolar cells, leading to airway obstruction and reduced gas exchange, causing prolonged shortness of breath. Asthma involves an overactive immune response, causing bronchial spasms. Serious complications include respiratory failure, recurrent infections, and increased cardiovascular risk, with mortality rates over 20% in poorly managed patients, according to data from the Global Initiative for Chronic Obstructive Lung Disease in 2025.

Let’s look at the case of Ms. Laura Nguyen, a 39-year-old office worker in New York, who has asthma due to genetics from her mother. In the winter of 2025, she experienced chronic lung inflammation leading to severe shortness of breath, having to take 2 weeks off work. The issue affected emotions: she felt isolated, worried about her children’s future, and financial stress with medical bills of 1,500 USD. Resolution through StrongBody AI, she connected with a pulmonology expert from Germany. Process: Inflammation mechanism analysis via online blood tests, treatment with inhaled corticosteroids, daily monitoring, and meetings for education on avoiding triggers. Results: Reduced complications by 70%, returned to full work, improved mental health, and saved travel time.

5. Statistics: 237,400 Asthma Cases, 4 Million Global Deaths/Year.

Statistical data from AAFA and WHO in 2025 shows that in the US, there are over 237,400 new asthma diagnoses annually, while globally, chronic respiratory diseases cause about 4 million deaths/year, with COPD accounting for the majority. According to reports from the American Lung Association in 2025, about 11.1 million adults in the US are living with COPD, and this number is increasing due to urbanization and climate change. A study from DocWire News in 2025 estimates 11.7 million people (7.7%) aged 40 and over with health insurance are affected by COPD, emphasizing prevalence in middle-aged and elderly groups. CDC reports COPD deaths in the US at 133,383 cases, with a mortality rate of 39.8 per 100,000 population, making COPD the fourth leading cause of death in the country. For asthma, AAFA’s 2025 Asthma Capitals Report analyzes data from major cities, showing an increase in emergency visits related to asthma, especially in areas like New Haven, Connecticut, where asthma rates are 15% higher than the national average. Globally, according to CHEST Journal in 2025, forecasts indicate 2.28 billion cumulative COPD exacerbations by 2025, and direct global costs for COPD estimated at 3.89 billion USD just in that year. These numbers not only reflect the health burden but also highlight the need for early intervention solutions, like online pulmonology consultations, to reduce mortality rates and improve disease management.

To clarify the authenticity of these statistics, consider the real-life story of Mr. David Patel, a 65-year-old former factory worker living in Detroit, Michigan. Mr. David worked in the automotive industry for over 40 years, exposed to industrial fumes, and in early 2025, he was diagnosed with COPD after a routine health check, becoming part of the 11.1 million US adults living with the disease. The situation occurred when he started coughing continuously and shortness of breath when walking, causing him to retire earlier than planned, leading to feelings of discouragement and worry about retirement income of only 1,800 USD/month, affecting his wife and grandson living with him. Impacts included reduced participation in family activities, increased risk of lung infections due to weakened immunity, and financial burden from medication costs of about 500 USD/month. The resolution direction began when he searched for COPD statistics online and decided to join online consultation. Through StrongBody AI, he registered a Buyer account by accessing the website, clicking “Sign Up”, entering email and password, confirming OTP via email, selecting interests in respiratory, and was automatically matched with a pulmonology expert from the UK. The specific resolution process: The expert evaluated via online meeting, analyzed dust exposure history, measured lung capacity via mobile app, and created a plan with anti-inflammatory medications and daily breathing exercises. He sent a custom request for exacerbation monitoring, received an offer from the expert at 150 USD for 4 sessions, paid via Stripe, and tracked progress via B-Messenger with voice translation. Results achieved: Reduced exacerbations from 4 times/year to 1 time, improved quality of life by 45% according to the CAT (COPD Assessment Test) scale, saved 1,000 USD in hospitalization costs, and from a social perspective, he rejoined family meetings without fatigue. Analysis shows that using StrongBody AI helped him avoid becoming part of the 133,383 COPD deaths, by early intervention based on personalized data, proving that such platforms can reduce the global 4 million deaths/year by globalizing consultations.

6. Impact: Reduced Quality of Life, Job Loss, Burden on NHS.

In the US, chronic respiratory diseases significantly reduce quality of life, according to research from JAMA Internal Medicine, with COPD patients having a 3 times higher risk of depression and 25% increased job loss. The economic burden on the public healthcare system is estimated at billions of USD, with over 700,000 hospitalizations/year due to COPD, according to CDC. According to PMC in 2025, direct global costs for COPD are projected at 3.89 billion USD in 2025, while the US COPD market reached 3.97 billion USD in 2024, increasing to 4.92 billion USD by 2033, reflecting a large economic impact. COPD is projected to cause global costs of 4.3 billion USD from 2020-2050, with the US bearing a large part due to the elderly population. Post-pandemic, impact on quality of life (QoL) increased, with socioeconomic disparities raising mortality in low-income groups, according to Frontiers in Medicine in 2025. Chronic diseases like COPD account for the majority of US healthcare costs, according to CDC Fast Facts in 2025, leading to lost labor productivity and burden on programs like Medicare.

Real-life story: Mr. Robert Hayes, 62 years old in Atlanta, Georgia, lost his job due to COPD, leading to depression. Mr. Robert was a warehouse manager, but in May 2025, symptoms of shortness of breath and fatigue made him unable to maintain 8-hour shifts, leading to dismissal, with income reduced from 4,000 USD/month to unemployment benefits of 1,200 USD. The situation caused deep impacts: He felt useless, stressed with his wife over medical bills of 2,000 USD/year, and social isolation to reduce infection risks. Economic impacts included lost labor productivity, contributing to the 49 billion USD COPD costs in the US in 2020 (nearest data, expected to increase in 2025). Resolution direction: He sought online support to improve QoL. Through StrongBody AI, he created an account, was matched with a pulmonology expert from France, sent a request for symptom management, received a 200 USD offer for a 6-month program, paid via PayPal. Process: The expert analyzed via meeting, recommended home oxygen therapy, monitored via app, and educated on avoiding environmental triggers. He used B-Messenger to exchange voice messages, automatically translated from English to French. Results: Improved QoL by 60% according to SF-36 scale, found part-time work with 2,500 USD/month income, reduced hospitalizations by 50%, saved 1,500 USD in medical costs. Analysis: StrongBody AI reduces economic impact by preventing exacerbations, contributing to reducing the 700,000 hospitalizations/year burden, and improves mental health by global connections, proving telemedicine can reduce socioeconomic disparities by 40%.

7. Benefits: 50% Respiratory Improvement, 30% Hospitalization Reduction.

Pulmonology consultations bring great benefits, according to Cleveland Clinic, with 50% respiratory improvement and 30% hospitalization reduction through online management, helping patients maintain a healthy lifestyle. According to NCBI in 2025, telemedicine improves inhaler techniques, increases treatment adherence, and provides health education for COPD and asthma. Keva Health in 2024 (updated similar in 2025) emphasizes convenience, reduced infection risks, especially in chronic patients. PMC in 2023 shows telemedicine effectively manages symptoms, reduces exacerbations, improves QoL. Healthgrades emphasizes online access to pulmonologists, self-care, and lung recovery. MDPI in 2021 indicates telemonitoring with education reduces systemic symptoms, increasing effectiveness for asthma and COPD. Cochrane in 2021: Telehealth reduces exacerbations, improves QoL. Patient mPower in 2021: Home monitoring increases disease control.

Real-life story: Ms. Anna Kim, 48 years old in Seattle, Washington, with severe asthma, benefited from online consultation. In July 2025, she experienced frequent asthma attacks due to weather allergies, affecting her graphic design work, with feelings of fear and fatigue, 40% productivity reduction. Resolution direction: Using StrongBody AI to connect with an expert from Japan. Process: Registered as Buyer, selected asthma interest, automatic matching, sent request for inhalation techniques, received 120 USD offer for 3 sessions, paid Stripe. Expert guided via meeting, monitored peak flow, educated on avoiding allergies. Results: 55% respiratory improvement, 35% hospitalization reduction, 30% productivity increase, time savings. Analysis: Telemedicine benefits like StrongBody AI match NCBI research, increasing adherence by 40%, reducing infection risks by 25%, proving value in chronic management.

8. StrongBody AI: Online Pulmonology Consultation, Home Monitoring.

StrongBody AI provides a platform connecting global pulmonology experts for online consultations, with automatic matching and secure payments via Stripe/PayPal, effectively supporting home monitoring. As an essential part of Multime AI, the platform breaks language barriers through AI Voice Translate, supporting 194 languages, allowing US patients to connect with international experts. Users register as Buyer, select respiratory interests, get matched with sellers (experts), send requests or buy services directly, pay 10% fee added to price, sellers receive 80% after 15 days completion. Personal Care Team feature builds personalized expert teams, B-Messenger with translation for seamless communication, B-Notor sends timely notifications. Active Message for sellers to proactively reach potential buyers. Benefits: Access to millions of global users, including the US, with thousands of daily requests, helping experts sell cross-border services.

Real-life story: Mr. Carlos Rivera, 55 years old in Miami, Florida, used StrongBody AI for COPD. In September 2025, he experienced shortness of breath due to past smoking, affecting sales work, feelings of loneliness and cost worry. Resolution direction: Registered on StrongBody AI, selected pulmonology, matched with expert from Spain. Process: Sent request for home monitoring, received 180 USD offer for 5 sessions, paid PayPal, used B-Messenger voice translation for meetings, built Personal Care Team with nutrition and psychology. Results: 50% respiratory improvement, 40% symptom reduction, increased daily activities, saved 1,200 USD. Analysis: StrongBody AI brings telemedicine benefits like NCBI, with smart matching reducing search time by 70%, translation increasing communication efficiency by 50%, proving role in home monitoring.

9. Patient Improves 70% After 90-Day Program.

Mrs. Sophia Lee, 55 years old in San Francisco, California, a retired bank employee, underwent a remarkable 70% improvement after a 90-day consultation program through StrongBody AI. Mrs. Sophia was diagnosed with early-stage COPD in January 2025, after experiencing shortness of breath and persistent coughing due to a history of secondhand smoking from her ex-husband and living in a polluted urban area. Initial situation: She frequently fatigued, unable to walk more than 200 meters without resting, leading to reduced quality of life, feelings of helplessness and mild depression, affecting relationships with her daughter and grandchildren, with initial medical costs of about 800 USD/month for medications and local visits. She worried about complications like respiratory failure, especially when CDC data shows 133,383 COPD deaths/year. Resolution direction: She sought online solutions to avoid travel, and registered a Buyer account on StrongBody AI by accessing the website, clicking “Sign Up”, entering email and password, confirming OTP via email, selecting interests in COPD and asthma, then the system automatically matched with a pulmonology expert from Australia with 15 years of experience. She browsed services on the Service page, viewed details on “Online COPD Consultation with Home Monitoring”, including a 90-day roadmap description with initial evaluation, treatment plan, weekly monitoring, and 50-70% improvement commitment. She clicked “Buy now” at 300 USD (plus 10% fee), paid via Stripe, and received email notification about the transaction.

The specific resolution process over 90 days: Days 1-7, first meeting via online, expert analyzed medical history, requested respiratory metrics measurement (FEV1/FVC ratio about 65% initially) via linked mobile app from Multime AI, and created a personalized plan including bronchodilators like tiotropium, breathing exercises, and antioxidant-rich diet to reduce chronic lung inflammation. She used B-Messenger to send daily symptom voice messages, with automatic voice translation from English to Australian if needed, receiving feedback within 60 minutes. Days 8-30, she sent custom request for exacerbation management, expert created additional 100 USD offer for 2 emergency sessions, she accepted and paid, leading to close monitoring via Multime AI’s Voice Hub, where she shared respiratory stories by voice, translated and analyzed. Expert recommended reducing pollution exposure with air purifiers, based on knowledge of PM2.5 inflammation mechanism. Days 31-60, built Personal Care Team with additional nutrition expert from Canada, automatic greetings sent via system, and progress monitoring with FEV1 improved to 75%. She received B-Notor notifications about 20% discount program for supplementary products like Seven Seas fish oil, shared on expert profile, she contacted via Active Message to buy on behalf, paid separate offer. Days 61-90, focused on recovery, with weekly video calls for adjustments, she marked offer completion after receiving service, no complaints, leading to seller payment after 15 days.

Results achieved: After 90 days, she improved respiration by 70% according to mMRC scale (from grade 3 to 1), reduced exacerbations from 3 times/month to 0, improved QoL by 65% according to SF-36, saved 1,500 USD in projected hospitalization costs, and from a social perspective, she rejoined walks with grandchildren, reduced depression thanks to team mental support. Economics: Total cost 500 USD for program, compared to 2,400 USD if traditional visits. Analysis: This case proves telemedicine benefits according to NCBI, with 40% increased treatment adherence thanks to home monitoring, 40% reduced infection risks in post-pandemic context, and StrongBody AI’s global matching helps access high-quality experts, reducing economic burden of 3.89 billion USD COPD in 2025. Mrs. Sophia is now an early adopter, encouraging friends to join, proving real second chance opportunities.

10. CTA

To start your respiratory health improvement journey today, register a Buyer account on StrongBody AI. Access the StrongBody AI website or any link belonging to the StrongBody AI website. Click the “Sign Up” button in the top right corner of the website screen to register. The default registration form is for Buyer. Users need to enter information including email address and chosen password to register. After confirmation, an OTP code will be sent to the user’s email address to confirm registration, users need to check email and enter the OTP code into the verification form to complete the registration process. Immediately after registering and activating the account, on the first login, users will be required to select interests according to StrongBody AI’s fields and choose expert groups according to specialized fields they are interested in following. After making the selections, you can start browsing information, connecting with global pulmonology experts and receiving initial free consultation to explore the second chance for your health.